Topic: commercial manufacturing
Novartis' AveXis is buying a former AstraZeneca production site in Colorado as part of the biotech's rapid manufacturing buildout.
Janssen's workers at a plant in California will be let go over the next three years, staring with nearly 50 being whacked next week.
Japan’s Nichi-Iko Pharmaceutical and its U.S. operation Sagent Pharmaceuticals have bought a plant in North Carolina from Xellia.
Pfizer is responding to a demand from a U.S. Attorney's office for records on EpiPens it manufactured for Mylan that failed during emergencies.
Novartis has reupped with Recro Pharma's CMO for production of two drugs, plus other news.
Immunomedics says it will meet with the FDA to discuss the CRL it got for manufacturing, while Teva has a new union agreement in place.
Progenics last year picked up an FDA approval for its orphan radiotherapeutic. Now it has picked up a manufacturing facility to produce it in.
The Sandoz manufacturing network will be further 'optimized' as Novartis turns Sandoz into an autonomous unit in the next 18 months.
A small piece of a campus in New York that was once owned by Wyeth and then Pfizer will now become home to a small drugmaker.
Pfizer has formed a partnership to manufacture some of its drugs in the rapidly growing Asian market.